0006-5085 : Prevymis 120 mg Oral Pellet


NDC: 0006-5085
Labeler: Merck Sharp & Dohme LLC
Product Type: Human Prescription Drug
Drug Name:  Prevymis
Dosage Form: Oral Pellet
Application #: NDA219104
Rev. Date: 


NDC Package Codes:

  • 0006-5085-01: 1 PACKET IN 1 CARTON (0006‑5085‑01) / 30 PELLET IN 1 PACKET

Active Ingredients:

  • Letermovir

Dosage Strength:

  • 120 mg

Pharmaceutical Classes:

  • Cytochrome P450 2C19 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
  • DNA Terminase Complex Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0006-5086 Prevymis 20 mg Oral Pellet by Merck Sharp & Dohme LLC
  • 0006-3075 Prevymis 240 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-3076 Prevymis 480 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-5003 Prevymis 20 mg/ml Intravenous Injection, Solution by Merck Sharp & Dohme Corp.
  • 0006-5004 Prevymis 20 mg/ml Intravenous Injection, Solution by Merck Sharp & Dohme Corp.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0006-5085 QR Code

< Prev: 0006-5083Next: 0006-5086 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.